Assessment of Sexual Dysfunction Rates and Associated Factors in Cancer Patients: A Systematic Review and Meta-Analysis
Clinical Scorecard: Assessment of Sexual Dysfunction Rates and Associated Factors in Cancer Patients: A Systematic Review and Meta-Analysis
At a Glance
| Category | Detail |
|---|
| Condition | Sexual Dysfunction in Cancer Patients |
| Key Mechanisms | Impact of cancer treatments on hormonal balance and body image leading to sexual health issues. |
| Target Population | Patients diagnosed with or surviving any type of cancer. |
| Care Setting | Oncology care settings. |
Key Highlights
- Sexual dysfunction affects 86-91% of patients with prostate, breast, and gynecological cancers.
- Prevalence rates range from 53-79% in head and neck, hematologic, and colorectal cancers.
- Only 2% of advanced cancer patients were sexually active despite 62% desiring intimacy.
- Barriers to addressing sexual health include patient reluctance and provider training gaps.
- Sexual health is critical for overall well-being and quality of life in cancer survivors.
Guideline-Based Recommendations
Diagnosis
- Utilize comprehensive assessments to evaluate sexual health in cancer patients.
Management
- Implement patient-centered approaches to address sexual dysfunction.
Monitoring & Follow-up
- Regularly assess sexual health as part of survivorship care.
Risks
- Recognize the psychological and functional barriers impacting sexual well-being.
Patient & Prescribing Data
Cancer patients across various types and treatment modalities.
Addressing sexual dysfunction is essential for improving quality of life.
Clinical Best Practices
- Encourage open discussions about sexual health between patients and providers.
- Provide training for healthcare providers on sexual health issues in cancer care.
- Integrate sexual health assessments into routine oncology evaluations.
References
